Filing summary
Entity mismatch: The request identifies T3 Defense Inc., but the supplied filing is for Nukkleus Inc. (ticker NUKK; warrants NUKKW). This summary covers the filing provided, not a T3 Defense filing.
Business context and reporting period
This unaudited Form 10-Q reports Nukkleus’s fiscal first quarter, the three months ended December 31, 2023, with comparison to the three months ended December 31, 2022. Nukkleus provides technology and support services to the retail foreign-exchange industry and payment services involving fiat and digital assets. Its business combination with Brilliant closed December 22, 2023 and was accounted for as a reverse recapitalization. The report was signed July 29, 2024.
Financial results and position
| Metric | Q1 fiscal 2024 | Comparable period |
|---|---|---|
| Revenue | $5.24 million | $5.38 million |
| Gross profit (loss) | $458,700 | $(54,873) |
| Operating expenses | $9.41 million | $1.08 million |
| Net loss | $(8.93) million; $(0.85) per share | $(1.13) million; $(0.11) per share |
| Operating cash flow | $(737,831) | $5.83 million |
- Revenue included $4.80 million of related-party general support services and $442,391 of financial services. The related-party service revenue was 91.6% of total revenue.
- Gross margin was approximately 8.8% overall, versus a gross loss in the prior period. General support services gross profit was $150,000; financial services gross profit was $308,700.
- Operating expenses included $6.15 million of bad-debt expense tied to a related-party receivable and approximately $2.02 million of stock issued for services. These were significant contributors to the larger net loss.
- At December 31, 2023, cash was $204,148, excluding $659,462 of customer custodial cash. Current assets were $1.96 million and current liabilities $11.62 million, producing a $9.66 million working-capital deficit. Total liabilities were $12.33 million; stockholders’ deficit was $9.95 million.
- Due to affiliates was $8.18 million, generally short-term, unsecured, non-interest-bearing and repayable on demand. Reported loan balances included $50,000 payable and $698,000 of related-party loans, plus $7,280 of related-party interest payable.
- Cash-flow cash at quarter-end was $863,610, including customer custodial cash; it should not be read as unrestricted operating cash. Financing cash flow was $746,171, including loans and reverse-recapitalization proceeds.
Material changes and unusual items
- Net loss increased by $7.79 million year over year, principally reflecting the bad-debt provision and higher professional fees. Financial services revenue fell 23.2%, while financial services costs fell 81.1%, largely because Match-related intangible assets had been impaired to zero in September 2023 and therefore no longer generated the same amortization expense.
- Management said it advised TCM that the related-party General Services Agreement (minimum monthly payment of $1.6 million) was terminated due to non-payment. The company does not expect near-term revenue under that agreement. The filing describes a $6.15 million related-party receivable allowance/write-off; investors should confirm its connection to TCM and any remaining collection rights.
- During the quarter, 425,295 shares were issued for services, valued at $2.02 million. Related-party debt conversions issued 827,807 shares; the excess fair value over converted debt was treated as a distribution. Total shares outstanding were 13,899,712 at quarter-end.
- Digital RFQ customer digital assets and matching liabilities were each $996,113 at quarter-end. The company states that it controls the relevant wallets/private keys and may face customer claims if assets are lost or stolen.
- Subsequent events disclosed include a May 2024 settlement arrangement involving $1.12 million of vendor payables to be exchanged for shares under specified pricing limits; June 2024 financing with a 12% note, conversion rights and warrants; and a July 2024 12% note and warrants. The June restructuring terms also restrict additional debt or equity financing without lender consent during the investment period and contemplate negotiating a sale of Digital RFQ, subject to approvals.
Liquidity, outlook, risks and controls
- Management states that available cash is insufficient to cover operating expenses for the 12 months from the report’s release date. The filing says these conditions raise substantial doubt about the company’s ability to continue as a going concern. Management expects to seek additional equity or debt financing, but says funding is not assured and may dilute shareholders or impose restrictive covenants.
- The company said financial-services revenue was expected to remain near its current level with minimal near-term increase. With the TCM agreement terminated, management did not expect near-term general support services revenue. No quantified earnings or revenue guidance was provided.
- Revenue, customers, suppliers and payables are highly concentrated among related parties. Related-party governance, counterparty payment/collection, customer asset custody, financing availability, and dilution are key risks.
- Management concluded disclosure controls and procedures were not effective at December 31, 2023 because previously reported material weaknesses had not been remediated. It stated additional analyses were performed and the financial statements were fairly stated in all material respects.
- The filing says the company was not a party to material legal proceedings. It also indicates it had not filed all reports required during the preceding 12 months.
Most important facts for investors to verify
- Confirm the intended issuer: this supplied filing is for Nukkleus Inc., not T3 Defense Inc.
- Verify the TCM agreement’s termination, the status and collectability of related-party receivables, and the basis for the $6.15 million bad-debt charge.
- Assess unrestricted liquidity, near-term obligations to affiliates, and whether subsequent financing proceeds and additional funding are sufficient to address the going-concern uncertainty.
- Review the full terms, share issuance limits and potential dilution from the SCC settlement and the June/July 2024 notes, conversion rights and warrants.
- Confirm remediation progress for the reported material weaknesses and the status of any proposed Digital RFQ sale.